Table 1.
Variables | Normal Range | Baseline | Chlorthalidone alone | Chlorthalidone plus Spironolactone | Chlorthalidone plus Irbesartan | ANOVA p |
---|---|---|---|---|---|---|
Age, years | 50.6±2.3 | |||||
BMI, kg/m2 | 30.1 ± 1.9 | |||||
Female, % | 35% | |||||
African Americans, % | 35% | |||||
24-hr SBP, mmHg | < 130 | 135.2±2.6 | 123.8±2.1* | 120.9±2.4* | 120.6±2.4* | 0.001 |
24-hr DBP, mmHg | < 80 | 83.5±2.1 | 77.6±2.1† | 75.3±2.0* | 74.9±2.1* | 0.003 |
24-hr HR, beats/min | 60–100 | 75±2 | 76±2 | 76±2 | 80±2 | NS |
Day SBP, mmHg | < 135 | 138.5±2.3 | 126.5±2.5* | 124.9±2.9* | 124.1±2.7* | 0.002 |
Day DBP, mmHg | < 85 | 86.6±2.1 | 79.9±1.7* | 78.1±1.5* | 76.8±1.9* | 0.004 |
Day HR, beats/min | 60–100 | 77±2 | 77±2 | 78±2 | 81±2 | NS |
Night SBP, mmHg | < 120 | 131.1±2.6 | 119.7±2.1* | 117.2±2.4* | 114.1±2.4* | 0.0003 |
Night DBP, mmHg | < 80 | 79.5±2.1 | 74.1±2.1† | 71.7±2.0* | 68.7±2.1* | 0.0007 |
Night HR, beats/min | 60–100 | 70±2 | 71±2 | 71±3 | 75±2† | 0.049 |
Casual SBP, mmHg | < 140 | 149.5±4.2 | 131.7± 2.3* | 132.9± 2.1* | 128.9± 3.2* | < 0.0001 |
Casual DBP, mmHg | < 90 | 88.0±2.1 | 80.9±1.3* | 81.3±2.1* | 80.5±1.8* | 0.0014 |
Casual HR, beats/min | 60–100 | 64±2 | 64±2 | 70±2 | 71±2 | NS |
PRA, ng/ml/hr | 0.05–3.3 | 0.44 | 3.27* | 5.01* | 13.62*§ | <0.0001 |
interquartile range | 0.05–1.16 | 0.84–7.93 | 2.39–11.50 | 5.73–17.67 | ||
Aldosterone (ng/dL) | < 21 | 5.3±1.5 | 9.2±1.4* | 10.8±2.2* | 13.3±5.1* | 0.013 |
Insulin, mU/L, median | < 12 | 3.9 | 7.6* | 4.87‡ | 6.8 | 0.024 |
interquartile range | 3.00–6.05 | 4.08–19.7 | 3.50–6.78 | 3.28–10.25 | ||
QUICKI | > 0.31 | 0.40±0.02 | 0.35±0.01* | 0.39±0.02‡ | 0.37±0.01 | 0.023 |
p < 0.01 vs baseline
p < 0.05 vs baseline
p = 0.02 vs chlorthalidone alone
p < 0.01 vs chlorthalidone alone